Personal information

Websites & social links

LinkedIn
Research Gate
Twitter

Other IDs

Loop profile: 1380433

Countries

United States

Activities

Collapse all

Employment (6)

Desna Therapeutics: San Diego, CA, US

2024-10 to present | Scientific Advisor (Immunology)
Employment
Source: Self-asserted source
Joseph S. Dolina

Arrowhead Pharmaceuticals: San Diego, CA, US

2024-07 to present | Scientific Advisor (Biology)
Employment
Source: Self-asserted source
Joseph S. Dolina

Pfizer: San Diego, CA, US

2019-09 to 2024-02 | Senior Scientist (Cancer Immunology Discovery, Oncology R&D Group)
Employment
Source: Self-asserted source
Joseph S. Dolina

Koliber Biosciences: San Diego, CA, US

2022-08 to 2023-01 | Scientific Advisor (Immunology)
Employment
Source: Self-asserted source
Joseph S. Dolina

La Jolla Institute for Immunology: La Jolla, CA, US

2014-07 to 2019-09 | Postdoctoral Research Fellow (Developmental Immunology)
Employment
Source: Self-asserted source
Joseph S. Dolina

University of Virginia: Charlottesville, VA, US

2013-08 to 2014-06 | Postdoctoral Research Fellow (Medicine)
Employment
Source: Self-asserted source
Joseph S. Dolina

Education and qualifications (6)

Pfizer: San Diego, CA, US

2020 to 2020 | Small Molecule Absorption, Distribution, Metabolism, and Excretion (ADME)
Qualification
Source: Self-asserted source
Joseph S. Dolina

University of Virginia: Charlottesville, VA, US

2007 to 2013 | Ph.D. (Microbiology)
Education
Source: Self-asserted source
Joseph S. Dolina

University of Minnesota: Minneapolis, MN, US

2008 to 2008 | AAI Advanced Course in Immunology
Qualification
Source: Self-asserted source
Joseph S. Dolina

Rutgers University (formerly University of Medicine and Dentistry of New Jersey): Newark, NJ, US

2006 to 2007 | M.S. (Biomedical Sciences)
Education
Source: Self-asserted source
Joseph S. Dolina

The College of New Jersey: Ewing, NJ, US

2002 to 2006 | B.S. (Biology)
Education
Source: Self-asserted source
Joseph S. Dolina

The College of New Jersey: Ewing, NJ, US

2002 to 2006 | B.S. (Chemistry)
Education
Source: Self-asserted source
Joseph S. Dolina

Professional activities (28)

New York Academy of Sciences: New York, NY, US

2022 to present | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

Society for Immunotherapy of Cancer: Milwaukee, WI, US

2021 to present | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

San Diego Entrepreneurs Exchange: San Diego, CA, US

2021 to present | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

Association for Cancer Immunotherapy: Mainz, DE

2019 to present | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

American Association for Cancer Research: Philadelphia, PA, US

2018 to present | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

American Association of Immunologists: Rockville, MD, US

2008 to present | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

Pfizer Global Research and Development La Jolla: La Jolla, CA, US

2021-01 | Pfizer William E. Upjohn Prizes Award (2×)
Distinction
Source: Self-asserted source
Joseph S. Dolina

Pfizer Global Research and Development La Jolla: La Jolla, CA, US

2021-01 | Pfizer Conversation Leaders Silver Reward
Distinction
Source: Self-asserted source
Joseph S. Dolina

Pfizer Global Research and Development La Jolla: La Jolla, CA, US

2020-12 | Pfizer William E. Upjohn Prizes Award (3×)
Distinction
Source: Self-asserted source
Joseph S. Dolina

American Association of Immunologists Inc: Rockville, MD, US

2019-05 | AAI Abstract Trainee Award, 103rd Annual Meeting of AAI, San Diego, CA
Distinction
Source: Self-asserted source
Joseph S. Dolina

National Postdoctoral Association: Washington, DC, US

2015 to 2019 | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

American Association of Immunologists Inc: Rockville, MD, US

2018-09 | AAI Travel Grant, 5th ECI, Amsterdam, Netherlands
Distinction
Source: Self-asserted source
Joseph S. Dolina

National Institutes of Health: Bethesda, MD, US

2018-08 | NIH T32 Immunology Training Grant
Distinction
Source: Self-asserted source
Joseph S. Dolina

La Jolla Institute for Immunology: La Jolla, CA, US

2018-03 | La Jolla Institute Postdoctoral Association Presentation Award, Lake Arrowhead, CA
Distinction
Source: Self-asserted source
Joseph S. Dolina

Midwinter Conference Council: Asilomar, CA, US

2018-01 | Ray Owen Young Investigator Award, 57th Midwinter Conference of Immunologists, Asilomar, Pacific Grove, CA
Distinction
Source: Self-asserted source
Joseph S. Dolina

American Association of Immunologists Inc: Rockville, MD, US

2017-05 | AAI Abstract Trainee Award, 101st Annual Meeting of AAI, Washington, DC
Distinction
Source: Self-asserted source
Joseph S. Dolina

American Association of Immunologists Inc: Rockville, MD, US

2016-08 | AAI Travel Grant, 16th ICI, Melbourne, Australia
Distinction
Source: Self-asserted source
Joseph S. Dolina

Midwinter Conference Council: Asilomar, CA, US

2016-01 | Midwinter Conference Council Award, 55th Midwinter Conference of Immunologists, Asilomar, Pacific Grove, CA
Distinction
Source: Self-asserted source
Joseph S. Dolina

American Society of Nephrology: Washington, DC, US

2013 to 2014 | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

American Association of Immunologists Inc: Rockville, MD, US

2012-05 | AAI Abstract Trainee Award for the 99th Annual Meeting of AAI, Boston, MA
Distinction
Source: Self-asserted source
Joseph S. Dolina

American Association of Immunologists Inc: Rockville, MD, US

2011-05 | AAI Abstract Trainee Award for the 98th Annual Meeting of AAI, San Francisco, CA
Distinction
Source: Self-asserted source
Joseph S. Dolina

American Association for the Advancement of Science: Washington, DC, US

2008 to 2010 | Member
Membership
Source: Self-asserted source
Joseph S. Dolina

National Institutes of Health: Bethesda, MD, US

2008-08 | NIH T32 Immunology Training Grant
Distinction
Source: Self-asserted source
Joseph S. Dolina

The College of New Jersey: Ewing, NJ, US

2006-05 | Joe Vena Senior Achievement Award in Biology
Distinction
Source: Self-asserted source
Joseph S. Dolina

The College of New Jersey: Ewing, NJ, US

2002-08 | TCNJ Honors Program
Distinction
Source: Self-asserted source
Joseph S. Dolina

The College of New Jersey: Ewing, NJ, US

2002-08 | TCNJ Merit Scholarship
Distinction
Source: Self-asserted source
Joseph S. Dolina

Higher Education Student Assistance Authority: Trenton, NJ, US

2002-08 | NJ Bloustein Scholarship
Distinction
Source: Self-asserted source
Joseph S. Dolina

Higher Education Student Assistance Authority: Trenton, NJ, US

2002-08 | NJ Outstanding Scholar Scholarship
Distinction
Source: Self-asserted source
Joseph S. Dolina

Funding (7)

Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers

2018-09 to 2023-08 | Grant
National Institutes of Health (Bethesda, MD, US)
GRANT_NUMBER:

U01 DE028227-01
Source: Self-asserted source
Joseph S. Dolina

Immunology Training Grant

2018-08 to 2019-07 | Grant
National Institutes of Health (Bethesda, MD, US)
GRANT_NUMBER:

T32 AI125179
Source: Self-asserted source
Joseph S. Dolina

Cellular and Molecular Regulation of CD8+ T Cell Memory

2013-05 to 2018-04 | Grant
National Institutes of Health (Bethesda, MD, US)
GRANT_NUMBER:

R01 AI107010-05
Source: Self-asserted source
Joseph S. Dolina

In vivo Delivery of Lipidoid Nanoparticles Containing PD-L1 siRNA

2009-10 to 2012-01 | Contract
Alnylam Pharmaceuticals (Cambridge, MA, US)
Source: Self-asserted source
Joseph S. Dolina

Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection

2009-06 to 2014-05 | Grant
National Institutes of Health (Bethesda, MD, US)
GRANT_NUMBER:

U19 AI083024-05
Source: Self-asserted source
Joseph S. Dolina

Immunology Training Grant

2008-07 to 2009-06 | Grant
National Institutes of Health (Bethesda, MD, US)
GRANT_NUMBER:

T32 AI007496-16A1
Source: Self-asserted source
Joseph S. Dolina

Role of NK in Regulation of Antiviral T Cell Immunity

2007-07 to 2014-03 | Grant
National Institutes of Health (Bethesda, MD, US)
GRANT_NUMBER:

R01 DK063222-08
Source: Self-asserted source
Joseph S. Dolina

Works (14)

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

The Journal of Clinical Investigation
2023-09-01 | Journal article
DOI: 10.1172/JCI164258
PMID: 37655661
Source: Self-asserted source
Joseph S. Dolina

Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors

Nature Immunology
2023-08-24 | Journal article
DOI: 10.1038/s41590-023-01543-9
PMID: 37400675
PMC: PMC10382322
Source: Self-asserted source
Joseph S. Dolina

Developmentally distinct CD4+ Treg lineages shape the CD8+ T cell response to acute Listeria infection

Proceedings of the National Academy of Sciences
2022-03-08 | Journal article
DOI: 10.1073/pnas.2113329119
PMID: 35239442
PMC: PMC8915796
Source: Self-asserted source
Joseph S. Dolina
grade
Preferred source (of 2)‎

Reversing T-cell exhaustion in cancer: lessons learned from PD-1/PD-L1 immune checkpoint blockade

Cancer Immunology Research
2022-02-01 | Journal article
DOI: 10.1158/2326-6066.CIR-21-0515
PMID: 34937730
Source: Self-asserted source
Joseph S. Dolina

Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties

Journal for ImmunoTherapy of Cancer
2021-12-13 | Journal article
DOI: 10.1136/jitc-2021-003614
PMID: 34903555
PMC: PMC8672007
Source: Self-asserted source
Joseph S. Dolina

CD8+ T cell exhaustion in cancer

Frontiers in Immunology
2021-07-20 | Journal article
DOI: 10.3389/fimmu.2021.715234
PMID: 34354714
PMC: PMC8330547
Source: Self-asserted source
Joseph S. Dolina

TLR9 sensing of self-DNA controls cell-mediated immunity to Listeria infection via rapid conversion of conventional CD4+ T cells to Treg

Cell Reports
2020-04-01 | Journal article
DOI: 10.1016/j.celrep.2020.01.040
PMID: 32268093
PMC: PMC8903023
Source: Self-asserted source
Joseph S. Dolina

Class-B CpG-ODN formulated with a nanostructure induces type I interferons-dependent and CD4+ T cell-independent CD8+ T-cell response against unconjugated protein antigen

Frontiers in Immunology
2018-10-10 | Journal article
DOI: 10.3389/fimmu.2018.02319
PMID: 30364187
PMC: PMC6192457
Source: Self-asserted source
Joseph S. Dolina

Cross-presentation of soluble and cell-associated antigen by murine hepatocytes is enhanced by collectrin expression

Journal of Immunology
2017-02-03 | Journal article
DOI: 10.4049/jimmunol.1502234
PMID: 28159899
Source: Self-asserted source
Joseph S. Dolina

Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice

Hepatology
2014-02-28 | Journal article
DOI: 10.1002/hep.26938
PMID: 24677194
PMC: PMC3970181
Source: Self-asserted source
Joseph S. Dolina

Lipidoid nanoparticles containing PD-L1 siRNA delivered in vivo enter Kupffer cells and enhance NK and CD8+ T cell-mediated hepatic antiviral immunity

Molecular Therapy Nucleic acids
2013-02-19 | Journal article
DOI: 10.1038/mtna.2012.63
PMID: 23423360
PMC: PMC3586800
Source: Self-asserted source
Joseph S. Dolina

Intrahepatic IL-10 maintains NKG2A+Ly49− liver NK cells in a functionally hyporesponsive state

Journal of Immunology
2010-02-01 | Journal article
DOI: 10.4049/jimmunol.0901362
PMID: 20124099
PMC: PMC2885840
Source: Self-asserted source
Joseph S. Dolina

Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system

PloS One
2009-10-30 | Journal article
DOI: 10.1371/journal.pone.0007619
PMID: 19876399
PMC: PMC2764869
Source: Self-asserted source
Joseph S. Dolina

Blue-side suppression of Ly α emission in quasars

The RBSE Journal
2001-05-14 | Journal article
OTHER-ID: https://noirlab.edu/public/media/archives/rbsejournals/pdf/rbsejournal01.pdf
Source: Self-asserted source
Joseph S. Dolina
How many people are using ORCID?